Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

GILEAD SCIENCES, INC.

(GILD)
  Report
Real-time Estimate Cboe BZX  -  12:40 2022-12-07 pm EST
87.66 USD   -0.34%
09:55aGilead Sciences, Inc. - New Data for Trodelvy Demonstrate Clinical Efficacy Across Trop-2 Expression Levels in HR+/HER2- Metastatic Breast Cancer
AQ
08:00aTranscript : Gilead Sciences, Inc. Presents at NASDAQ 47th Investor Conference, Dec-07-2022 01:00 PM
CI
12/06New Data for Trodelvy Demonstrate Clinical Efficacy Across Trop-2 Expression Levels in HR+/HER2- Metastatic Breast Cancer
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart GILEAD SCIENCES, INC.
Upcoming events on GILEAD SCIENCES, INC.
12/07/22 | 08:00am Nasdaq Investor Conference
12/10/22 | 02:30pm American Society of Hematology Meeting - Abstract #261
12/10/22 | 02:45pm American Society of Hematology Meeting - Abstract #262
12/10/22 | 05:30pm American Society of Hematology Meeting - Abstract #2274
12/10/22 | 05:30pm American Society of Hematology Meeting - Abstract #2022
12/10/22 | 05:30pm American Society of Hematology Meeting - Abstract #2038
12/10/22 | 05:30pm American Society of Hematology Meeting - Abstract #1368
12/10/22 | 05:30pm American Society of Hematology Meeting - Abstract #2039
12/10/22 | 05:30pm American Society of Hematology Meeting - Abstract #1981
12/10/22 | 05:30pm American Society of Hematology Meeting - Abstract #1581
Past events on GILEAD SCIENCES, INC.
11/30/22 | 11:30am Piper Sandler Healthcare Conference
11/29/22 | 01:00pm Evercore ISI HealthCONx Conference
11/04/22 American Association for the Study of Liver Diseases Meeting - Poster 4743
11/04/22 American Association for the Study of Liver Diseases Meeting - Poster 2324
11/04/22 American Association for the Study of Liver Diseases Meeting - Poster 1245
11/04/22 American Association for the Study of Liver Diseases Meeting - Oral 52
11/04/22 American Association for the Study of Liver Diseases Meeting - Oral 76
11/04/22 American Association for the Study of Liver Diseases Meeting - Poster 3469
11/04/22 American Association for the Study of Liver Diseases Meeting - Oral 1296
11/04/22 American Association for the Study of Liver Diseases Meeting - Oral 75
Past dividends on GILEAD SCIENCES, INC.
09/14/22 Quarterly 0.73 USD
06/14/22 Quarterly 0.73 USD
03/14/22 Quarterly 0.73 USD
12/14/21 Quarterly 0.71 USD
09/14/21 Quarterly 0.71 USD
06/14/21 Quarterly 0.71 USD
03/12/21 Quarterly 0.71 USD
12/14/20 Quarterly 0.68 USD
09/14/20 Quarterly 0.68 USD
06/11/20 Quarterly 0.68 USD
Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
26 107
25 842
1,0%
22 127
21 839
1,3%
22 449
22 305
0,65%
24 689
24 482
0,84%
27 305
26 673
2,4%
 
26 521
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
17 317
16 841
2,8%
12 840
12 564
2,2%
12 468
13 029
-4,3%
13 184
13 142
0,32%
14 598
15 568
-6,2%
 
14 043
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
16 031
16 041
-0,06%
11 411
11 753
-2,9%
11 064
11 571
-4,4%
11 704
11 599
0,90%
12 548
13 965
-10%
 
12 145
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
13 529
13 843
-2,3%
7 799
9 060
-14%
5 160
5 333
-3,2%
1 669
1 636
2,0%
8 278
9 507
-13%
 
5 658
 
Net income
M $
Released
Forecast
Spread
4 628
10 263
-55%
5 455
7 207
-24%
5 386
4 292
26%
123
137
-10%
6 225
7 205
-14%
 
4 384
 
EPS
$
Released
Forecast
Spread
3,51
7,71
-54%
4,17
5,47
-24%
4,22
3,43
23%
0,10
0,12
-16%
4,93
5,75
-14%
 
3,60
 
Announcement Date02/06/201802/04/201902/04/202002/04/202102/01/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread
7 421
6 333
17%
7 244
6 635
9,2%
6 590
6 279
5,0%
6 260
5 873
6,6%
7 042
6 133
15%
 
6 649
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
4 902
3 922
25%
2 042
3 632
-44%
4 049
3 438
18%
3 195
3 183
0,38%
3 811
3 049
25%
 
2 885
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
4 379
3 126
40%
1 507
2 931
-49%
3 524
3 060
15%
2 670
2 602
2,6%
3 286
2 529
30%
 
2 607
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
3 438
1 953
76%
759
1 966
-61%
-152
2 158
-107%
1 503
1 664
-9,7%
2 432
1 674
45%
 
1 840
 
Net income
M $
Released
Forecast
Spread
2 592
1 769
47%
382
1 424
-73%
19,0
1 611
-99%
1 144
1 367
-16%
1 789
1 248
43%
 
1 447
 
EPS
$
Released
Forecast
Spread
2,05
1,37
50%
0,30
1,14
-74%
0,02
1,34
-99%
0,91
1,11
-18%
1,42
1,01
41%
 
1,12
 
Announcement Date10/28/202102/01/202204/28/202208/02/202210/27/2022-
Previous year Next Year
Upcoming sector events for GILEAD SCIENCES, INC.
More events
Past sector events for GILEAD SCIENCES, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise